The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review.

Publikation

The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review.

Wissenschaftlicher Artikel/Review - 24.11.2023

Bessat Cécile, Boillat-Blanco Noémie, Albrich Werner

Zitation

Bessat C, Boillat-Blanco N, Albrich W. The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review. Expert Rev Respir Med 2023; 17:919-927.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Expert Rev Respir Med 2023; 17

Veröffentlichungsdatum

24.11.2023

eISSN (Online)

1747-6356

Seiten

919-927

Kurzbeschreibung/Zielsetzung

Lower respiratory tract infections (LRTIs) are among the most frequent infections and are prone to inappropriate antibiotic treatments. This results from a limited accuracy of diagnostic tools in identifying bacterial pneumonia. Lung ultrasound (LUS) has excellent sensitivity and specificity in diagnosing pneumonia. Additionally, elevated procalcitonin (PCT) levels correlate with an increased likelihood of bacterial infection. LUS and PCT appear to be complementary in identifying patients with bacterial pneumonia who are likely to benefit from antibiotics.